Related references
Note: Only part of the references are listed.Eosinophils Express Muscarinic Receptors and Corticotropin-Releasing Factor to Disrupt the Mucosal Barrier in Ulcerative Colitis
Conny Wallon et al.
GASTROENTEROLOGY (2011)
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Epithelial Tight Junctions in Intestinal Inflammation
Joerg D. Schulzke et al.
MOLECULAR STRUCTURE AND FUNCTION OF THE TIGHT JUNCTION: FROM BASIC MECHANISMS TO CLINICAL MANIFESTATIONS (2009)
Clinical relevance of measuring colonic permeability
V. Haas et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse
M. C. Arrieta et al.
GUT (2009)
MAGI2 Genetic Variation and Inflammatory Bowel Disease
Dermot P. B. McGovern et al.
INFLAMMATORY BOWEL DISEASES (2009)
Risk Factors and Characteristics of Extent Progression in Ulcerative Colitis
Maria Josefina Etchevers et al.
INFLAMMATORY BOWEL DISEASES (2009)
Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region
Jeffrey C. Barrett et al.
NATURE GENETICS (2009)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
Dorota Walkiewicz et al.
INFLAMMATORY BOWEL DISEASES (2008)
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
E. F. Stange et al.
JOURNAL OF CROHNS & COLITIS (2008)
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease
Sheila A. Fisher et al.
NATURE GENETICS (2008)
Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis
M. C. Wapenaar et al.
GUT (2008)
Absence of functional peroxisome proliferator-activated receptor-α enhanced ileum permeability during experimental colitis
Emanuela Mazzon et al.
SHOCK (2007)
Altered intestinal permeability is predictive of early relapse in children with steroid-responsive ulcerative colitis
E. Miele et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis
Alexander Swidsinski et al.
INFLAMMATORY BOWEL DISEASES (2007)
Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease
R D'Incà et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Thalidomide treatment reduces the alteration of paracellular barrier function in mice ileum during experimental colitis
E Mazzon et al.
SHOCK (2006)
Genetic basis for increased intestinal permeability in families with Crohn's disease:: role of CARD15 3020insC mutation?
S Buhner et al.
GUT (2006)
Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases
M Pierik et al.
INFLAMMATORY BOWEL DISEASES (2006)
Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy
W Fries et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Subclinical alveolar involvement in ulcerative colitis
S Gursoy et al.
INFLAMMATORY BOWEL DISEASES (2005)
51CrEDTA colonic permeability and therapy response in patients with ulcerative colitis
G Arslan et al.
NUCLEAR MEDICINE COMMUNICATIONS (2001)
Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk
EJ Irvine et al.
GASTROENTEROLOGY (2000)